1st Annual Translational Oncology Symposium

Bridging the Gap between Cancer Research and the Clinic

Date: Thursday, November 14th, 2019

Location: The California Academy of Sciences, Golden Gate Park
55 Music Concourse Dr., San Francisco, CA 94118
Time: 8am – 5pm, followed by a Happy Hour networking event

Champions Oncology San Francisco Symposium

Registration Now Open

Cancer’s complexity is more apparent with every discovery made in the field. Learn from industry leaders about critical successes and challenges that they face in this ever-changing therapeutic area.

Gain insights on how to support your translational oncology and Immuno-Oncology programs from the bench to the clinic, by attending Champions Oncology’s Translational Oncology Symposium in San Francisco in November.

Reserve your seat now – Free Registration but seats are limited!


Who should attend?

R&D, discovery, preclinical and translational teams from pharma, biotech, and academia

Speaker Presentations

Gina Wei, PhD

QED Therapeutics – Director, Translational Medicine


Case studies of utilizing PDX models for tumor-agnostic anti-cancer molecular label targeting rare gene alterations


Stephen Dann, PhD

Pfizer – Associate Research Fellow


Cell cycle intervention beyond palbociclib; preclinical discovery of the CDK2/4/6 inhibitor PF-06873600


Rathin Das, PhD, MBA

Synergys Biotherapeutics, Inc. – CEO



Targeting Vasculogenic Mimicry in Triple Negative Breast Cancer


Grace Lee, PhD

REVOLUTION Medicines – Scientist II, Cancer Pharmacology


Leveraging PDX models to explore SHP2i-sensitive genotypes


Kevin Yang, PhD

REVOLUTION Medicines – Scientist II, Cancer Pharmacology


Bi-steric mTOR inhibitors selectively inhibit mTORC1 and demonstrate marked efficacy in preclinical models


Amy Wesa, PhD

Champions Oncology – Director, Immuno-Oncology Research


Emerging preclinical models in oncology: ex vivo platforms and humanized mouse models


Greg Bannish, PhD

Champions Oncology – Head of Flow Cytometry


Optimizing flow cytometry results during preclinical and clinical drug development


Janell Richardson, PhD

Taconic Biosciences – Field Application Specialist


The Jh (B-cell deficient) mouse in the current IO landscape


Sourav Bandyopadhyay, PhD

University of California, San Francisco – Associate Professor, Bioengineering & Therapeutic Sciences


Targeting a mitotic driver of tumor evolution and EGFR TKI resistance in NSCLC


Ray Price, PhD, EMBA

PhenoVista Biosciences – VP, Business Development


Novel imaging applications for models of the tumor microenvironment


Sharsti Sandall, PhD

Seattle Genetics, Principal Scientist, Cancer Biology

Using PDX models to better understand ADC biology


Join us for a day full of scientific insights and professional networking at Champions Oncology Translational Oncology Symposium!

A continental breakfast and coffee will be provided prior to the start of the symposium, as well as lunch will be provided onsite. Happy Hour with hors d’oeuvres and drinks, will be provided following the Symposium.

Complimentary access to the Academy of the Sciences Nightlife event onsite at 6pm will be provided.

Register now to attend!